or Try an Advanced Search...

    Technical Analysis for GNPX - Genprex, Inc.

    Grade Last Price % Change Price Change
    F 2.45 -2.20% -0.06
    GNPX closed down 2.53 percent on Wednesday, May 15, 2024, on 77 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: May 22
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical GNPX trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.20%
    NR7 Range Contraction -2.20%
    Upper Bollinger Band Walk Strength -2.20%
    Inside Day Range Contraction -2.20%
    20 DMA Support Bullish -4.67%
    Pocket Pivot Bullish Swing Setup -4.67%
    BB Squeeze Ended Range Expansion -4.67%
    Outside Day Range Expansion -4.67%
    Upper Bollinger Band Touch Strength -4.67%
    20 DMA Support Bullish 2.51%
    Older End-of-Day Signals for GNPX ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 2 hours ago
    Rose Above Upper Bollinger Band about 2 hours ago
    Up 5% about 2 hours ago
    Up 3% about 2 hours ago
    Up 2% about 2 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    GNPX Chart by TradingView
    Basic chart:

    Profile

    Genprex Inc is a clinical stage gene therapy company. It develops therapies that carry cancer-fighting genes. Its initial product candidate is Oncoprex.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Biology Gene Therapy Medical Genetics Applied Genetics Medicinal Chemistry

    Is GNPX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 Genprex co-founder, CEO passes away
    May 8 Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
    May 7 Sidoti Events, LLC's Virtual May Micro-Cap Conference
    Apr 4 Genprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
    Apr 3 Genprex expands clinical trial sites for study to treat small cell lung cancer
    Apr 3 Genprex Expands Clinical Trial Sites for Acclaim-3 Clinical Study of Reqorsa® Therapy in Combination with Tecentriq® to Treat Small Cell Lung Cancer
    Apr 2 Genprex Collaborators Publish Positive Preclinical Data with NPRL2 Gene Therapy Utilizing Oncoprex® Delivery System
    Mar 19 Genprex Announces $6.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Mar 19 Genprex falls 10% after pricing its offering to raise $6.5M
    Mar 12 Genprex Receives Notice of Patent Grant for Korean Patent Claiming Reqorsa® Immunogene Therapy with PD-1 and PD-L1 Antibodies to Treat Cancers
    See more GNPX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 42.4
    52 Week Low 2.09
    Average Volume 58,765
    200-Day Moving Average 10.07
    50-Day Moving Average 2.90
    20-Day Moving Average 2.33
    10-Day Moving Average 2.44
    Average True Range 0.29
    RSI (14) 48.19
    ADX 15.8
    +DI 20.30
    -DI 14.41
    Chandelier Exit (Long, 3 ATRs) 1.88
    Chandelier Exit (Short, 3 ATRs) 2.95
    Upper Bollinger Bands 2.61
    Lower Bollinger Band 2.05
    Percent B (%b) 0.81
    BandWidth 23.71
    MACD Line -0.12
    MACD Signal Line -0.19
    MACD Histogram 0.0763
    Fundamentals Value
    Market Cap 3.72 Million
    Num Shares 1.49 Million
    EPS -24.40
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 0.00
    Price-to-Book 0.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.76
    Resistance 3 (R3) 2.76 2.67 2.72
    Resistance 2 (R2) 2.67 2.60 2.67 2.70
    Resistance 1 (R1) 2.59 2.56 2.54 2.59 2.69
    Pivot Point 2.50 2.50 2.48 2.50 2.50
    Support 1 (S1) 2.42 2.43 2.37 2.42 2.32
    Support 2 (S2) 2.33 2.39 2.33 2.31
    Support 3 (S3) 2.25 2.33 2.29
    Support 4 (S4) 2.25